Open Access
Review
Table 1.
Summary of studies assessing the efficiency of BMAC in the management of rotator cuff tears.
| Study ID | Design | Population | Intervention | Comparator | Outcome measure | Findings |
|---|---|---|---|---|---|---|
| Ellera Gomes et al. [41] | Single arm prospective study | Fourteen patients (nine women, five men) with full thickness rotator cuff tears | Trans-osseous stitches augmented with BMAC utilizing a mini-open technique | No control | University of California Los Angeles | From 12 ± 3.0 to 31 ± 3.2 |
| Tendon integrity (12 months) | Tendon integrity was maintained in 100% of cases. | |||||
| Hernigou et al. [20] | Prospective, matched-control, study | Fifty-four patients | BMAC in augmenting arthroscopic single row rotator cuff repair | Matched control group of 45 patients without augmentation with BMAC | Tendon integrity (six months) | 100% vs. 67% |
| Tendon integrity (10 years) | 87% vs. 44% | |||||
| Centeno et al. [44] | Prospective multicentre cohort study | Patients with osteoarthritis with and without rotator cuff pathology | BMAC injection for the gleno-humeral OA | None |
|
|
| Havlas et al. [43] | Prospective, matched-control, study | Forty-five patients | BMAC in augmenting arthroscopic single row rotator cuff repair | Matched control group of 45 patients without augmentation with BMAC | Tendon integrity (6 months) | (100%) compared to 30 (67%) |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.